Microtubules (MTs) are the fundamental structural elements of all cells that govern a myriad of cellular functions, including motility, maintenance of cell morphology, intracellular transport, mitosis and meiosis. A dynamic equilibrium exists between the assembly and disassembly of the MT network during the different phases of cell cycle.^[@bib1]^ Proper assembly, positioning and orientation of the mitotic spindle are finely orchestrated by molecular players, like the dynein/dynactin complex that ensure correct spindle formation and generate the pulling forces required for proper cell division.^[@bib2],\ [@bib3],\ [@bib4]^ These proteins are enriched at the spindle poles, and the disruption of a functional dynamin/dynactin motor protein complex impairs mitotic spindle morphology.^[@bib5],\ [@bib6]^

Recent reports indicate that Huntingtin (HTT) protein, mutations of which cause Huntington\'s disease (HD), localizes to spindle poles throughout mitosis. Downregulation of HTT in primary cells affects motor proteins and leads to spindle misorientation that translates to defects in murine neuronal progenitors and neuroblast precursors in Drosophila.^[@bib7]^

Furthermore, Parkin, a ubiquitin E3 ligase,^[@bib8]^ is also a tubulin-binding protein. Parkin--tubulin interaction in human cell lines leads to increased ubiquitination and accelerated degradation of *α*- and *β*-tubulins. Point mutants of Parkin (K161N, T240R and C431H) identified in Parkinson\'s disease (PD) patients are incompetent in the E3 ligase activity toward tubulins.^[@bib9]^

The role of post-translational modifications of tubulin, such as acetylation, methylation, detyrosination, glutamylation and glycation in MT formation and regulation, has been studied.^[@bib10]^ However, our understanding of ubiquitination of tubulin is still premature and is primarily focused on regulating its degradation and turnover.

Recent reports indicate that BRCA1 (breast cancer-associated gene 1) protein binds to and ubiquitinates *γ*-tubulin that is crucial for maintaining appropriate centrosome number in cells.^[@bib11],\ [@bib12],\ [@bib13],\ [@bib14]^ In addition, mutations in ubiquitin C-terminal hydrolase L1 (UCH L1), a cysteine hydrolase,^[@bib15]^ expressed abundantly and exclusively in brain and reproductive tissues,^[@bib16]^ are associated with PD and Alzheimer\'s diseases (AD).^[@bib17]^ Studies show that besides being a deubiquitinating enzyme, UCH L1 dimers have ubiquitin ligase activity *in vitro* and stabilize monoubiquitin in neurons.^[@bib18],\ [@bib19],\ [@bib20]^

Prion diseases such as HD, PD and AD are late-onset neurodegenerative diseases. Prion protein (PrP), a highly conserved cell surface glycoprotein, is implicated in several of the prion diseases such as scrapie, bovine spongiform encephalopathy, Creutzfeldt--Jakob disease and Gerstmann--Straussler--Scheinker disease. Their pathogenesis is associated with the presence in brain of one or more abnormal isoforms of PrP (misfolded form of PrP (PrP^Sc^), transmembrane isoform (^Ctm^PrP) and cytoplasmic (cyPrP)).^[@bib21]^ Although the mechanisms leading to disease are not fully understood, recent reports suggest that some of the disease-causing isoforms of PrP can engage in atypical interactions with the cytosolic E3 ligase, mahogunin ring finger-1 (MGRN1). This results in inappropriate sequestration of MGRN1 in cell culture systems, and might contribute to late-onset neuronal dysfunction and disease,^[@bib22]^ similar to homozygous loss of MGRN1 function leading to late-onset spongiform neurodegeneration in mice.^[@bib23]^ However, the role played by MGRN1 in prion diseases caused by PrP^Sc^ may not be as evident.^[@bib24]^

Separate studies indicate that although ∼50% of MGRN1-null mutants in mice develop late-onset spongiform neurodegeneration, rest of the animals exhibit severe developmental defects (like congenital heart defects, abnormal craniofacial patterning and mispatterning of the left--right (LR) body axis) and increased mortality by weaning age. In addition, \<1% of animals also suffered from situs inversus (complete reversal of the left and right body axes).^[@bib25],\ [@bib26]^ Hence, the effect of loss of function of MGRN1 on cell viability and ultimately on the development of animals seemed likely.

Here, we describe the serendipitous discovery of an interaction between MGRN1 and the cytoskeletal protein, *α*-tubulin; and its effect on the axis of cell division during mitosis. Depletion of MGRN1 in cells affects ubiquitination of *α*-tubulin, altering its polymerization state and not the protein turnover. Our analysis identifies a unique mode of ubiquitination of *α*-tubulin by MGRN1 (utilizing K6 ubiquitin linkages) as a novel post-translation modification of this cytoskeletal protein, responsible for the formation and maintenance of the mitotic spindle fibers.

Results
=======

Interaction of endogenous MGRN1 with *α*-tubulin in mitotic cells
-----------------------------------------------------------------

We observed in HeLa cells that the typical punctate/vesicular pattern of expression of endogenous MGRN1 with an obvious nuclear exclusion as seen in interphase cells gets altered and it now decorates mitotic spindles in dividing cells ([Figure 1a](#fig1){ref-type="fig"}). This pattern of close association of MGRN1 with mitotic apparatus could be detected through the different stages of mitosis (M phase) ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). Co-immunoprecipitation of synchronized cells indicates an interaction between MGRN1 and *α*-tubulin ([Figures 1b and c](#fig1){ref-type="fig"} and [Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}) and this requires the C-terminus of MGRN1 ([Figure 1d](#fig1){ref-type="fig"} and [Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). Co-immunocytochemistry also showed their pronounced colocalization on mitotic spindles ([Figure 1e](#fig1){ref-type="fig"}). Similar results were noted in mitotic HEK293T (human embryonic kidney 293 transformed with T-antigen) cells ([Figure 1f](#fig1){ref-type="fig"}), suggesting a cell line-independent phenomenon. Furthermore, co-immunoprecipitation of melanocytes^[@bib27]^ ([Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}) demonstrates an interaction between MGRN1 and *α*-tubulin in melan a-6 (control) cells when compared with melan md1-nc (*Mgrn1*^md*-nc*^ or *Mgrn1* null) cells ([Figures 1g and h](#fig1){ref-type="fig"}). These observations led to the following plausible hypotheses -- either association with MGRN1 regulates the turnover of *α*-tubulin or MGRN1 ubiquitinates *α*-tubulin to affect its function. However, an indirect interaction with the spindle assembly via the dynein/dynactin complex seemed unlikely.

Catalytically inactive MGRN1 affects the axis of cell division
--------------------------------------------------------------

To understand the functional significance of the interaction between MGRN1 and *α*-tubulin, cells were transiently transfected with full-length (referred to as MGRN1) or a catalytically inactive MGRN1, lacking the RING domain (MGRN1ΔR), or with point mutations (C316DMGRN1, C299EMGRN1) in the same domain ([Supplementary Figures S2A and B](#sup1){ref-type="supplementary-material"}). Although HeLa cells transiently transfected with MGRN1ΔR completed M phase of cell cycle with a mitotic index comparable to those expressing either cytosolic green fluorescent protein (GFP) or MGRN1 ([Supplementary Figure S1E](#sup1){ref-type="supplementary-material"}), they displayed spindle misorientation.^[@bib28]^ The spindle angle relative to the cell substrate adhesion plane ([Supplementary Figure S2C](#sup1){ref-type="supplementary-material"}) for MGRN1 RING mutant-expressing cells (∼55--70%, depending on the construct) was \>10°, whereas control spindles were usually parallel to the substratum ([Figures 2a and b](#fig2){ref-type="fig"} and [Supplementary Figures S2 D and E and S3A](#sup1){ref-type="supplementary-material"}). Whereas control cells show an angle mostly around 10°, the average angle upon functional inactivation of MGRN1 was significantly higher (between 15° and 30°), indicating aberrant spindle orientation relative to the substratum ([Figures 2b and d](#fig2){ref-type="fig"} and [Supplementary Figure S2E](#sup1){ref-type="supplementary-material"}; right graphs). This phenotype was even more pronounced when MGRN1 was depleted from cells using small interfering RNA (siRNA) constructs (with knockdown efficiency of ∼75%), where spindle tilt of \>10° was seen in ≥80% of cells ([Figures 2c and d](#fig2){ref-type="fig"}). Such experiments with catalytically inactive MGRN1 were possible only with transient transfections as three attempts to establish stable cell lines failed (data not shown); on the contrary, we could easily establish stable cells expressing full-length MGRN1 ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). Although no drastic effect of functionally inactive MGRN1 is obvious on the mitotic index or the completion of mitosis in the short term ([Supplementary Figure S1E](#sup1){ref-type="supplementary-material"}), the effect of spindle misorientation had a cumulative detrimental effect over multiple cycles of cell division.

We next examined the structural underpinnings of spindle misorientation induced by MGRN1 inactivation/depletion. The most notable defect was a significant loss and shortening of astral MTs that did not contact the cell cortex, a requirement for force generation during spindle orientation ([Figures 2e--h](#fig2){ref-type="fig"}).

We also evaluated the effect of MGRN1 inactivation on the motor protein, dyenin1, as it is important for spindle pole assembly and orientation.^[@bib7],\ [@bib28]^ Immunocytochemistry showed a decrease in dynein staining at the poles when MGRN1 was depleted compared with the control cells ([Figures 3a and b](#fig3){ref-type="fig"}). However, the spread and pattern of distribution of dynein at and around the spindle poles remained very similar in both the cell populations ([Figure 3c](#fig3){ref-type="fig"}). These results imply that the decrease in detectable dyenin at the spindle pole might be due to its reduced association with polymerized *α*-tubulin when MGRN1 is functionally inactive, rather than a direct effect on the inhibition in dynein/dynactin-dependent transport.^[@bib7],\ [@bib29]^

MGRN1 affects *α*-tubulin polymerization
----------------------------------------

As mitotic spindles and asters are dynamic microtubule-based structures, we depolymerized microtubules with nocodazole (Noc) and followed their regrowth after washout of the drug in HeLa cells transiently expressing MGRN1, MGRN1ΔR or MGRN1 C316D at various time points ([Figures 3d and e](#fig3){ref-type="fig"} and [Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}). Peripheral MT clusters, representing ectopic poles, were marginally more in number (1.5--1.7 times, across time points) upon functional inactivation of MGRN1 when compared with the control cells ([Figure 3e](#fig3){ref-type="fig"}). This difference remained very similar over the entire time period of the experiment, indirectly pointing to the fact that motor proteins do not directly govern this phenotype.

Furthermore, to biochemically establish the interaction between MGRN1 and polymerized MTs, co-sedimentation assay was performed using synchronized mitosis-enriched HeLa cell lysates. Results indicated that MGRN1 co-pelleted with taxol-stabilized MTs and not with Noc (negative control) ([Figure 4a](#fig4){ref-type="fig"}).

Finally, to check the status of endogenous microtubule polymerization in unsynchronized population of cells, HeLa cells and wild-type mouse embryonic fibroblasts (MEFs; , primary cells) were transiently transfected with the indicated MGRN1 constructs. At 24 h after transfection, the cells were lysed, 1/15th of this was retained for analysis as total lysate control and the rest was separated into soluble (supernatant (S)) and insoluble (pellet (P)) fractions and biochemically analyzed to detect any change in *α*-tubulin polymerization among the samples ([Figures 4b--g](#fig4){ref-type="fig"}). Melanocytes (melan a-6 and melan md1-nc) cells were grown for 24 h, similarly fractionated and analyzed by western blots for the levels of *α*-tubulin. Our results showed that although the S/P ratio is ∼1 in control HeLa cells expressing cytosolic GFP or MGRN1; the ratio is \>2.5 in cells overexpressing catalytically inactive MGRN1 (MGRN1ΔR or MGRN1316D), hence indicating a decrease in the polymerized form of *α*-tubulin ([Figures 4b and c](#fig4){ref-type="fig"}). Similarly, the S/P ratio was \>3 in the presence of MGRN1 siRNA as compared with control (S/P≈2; [Figures 4d and e](#fig4){ref-type="fig"}). The most pronounced change was observed with wild-type MEFs in a similar experiment -- with S/P ratio of ∼3.6 upon overexpression of MGRN1ΔR compared with the MGRN1 control having S/P ratio of ∼1.4 ([Figures 4f and g](#fig4){ref-type="fig"}). These samples when analyzed for changes in *β*-tubulin polymerization failed to elicit similar differences, irrespective of the functional status of MGRN1 ([Figures 4j--m](#fig4){ref-type="fig"}). In melanocytes, whereas the S/P ratio was ∼1.9 for melan a-6, it was ∼3 for melan md1-nc cells ([Figures 4h and i](#fig4){ref-type="fig"}).

Furthermore, in Noc washout experiments with HeLa cells expressing MGRN1, MGRN1ΔR or C316DMGRN1 to study the MT network, the interphase cells showed that catalytic inactivation of MGRN1 distinctly compromised formation of a polymerized mesh -- the MGRN1ΔR- or C316DMGRN1-expressing cells lag behind the MGRN1 cells by ∼30 min ([Figure 5a](#fig5){ref-type="fig"} and [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). siRNA-mediated depletion of MGRN1 also severely affected microtubule re-assembly ([Figure 5b](#fig5){ref-type="fig"}). Wild-type MEFs subjected to similar microtubule regrowth assay after Noc treatment over a period of 10 and 15 min show a very punctate *α*-tubulin expression pattern in MGRN1ΔR cells as compared with a well-polymerized *α*-tubulin network and MT cluster nucleation centers in MGRN1 cells ([Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}). Immunocytochemistry showed that like HeLa cells, MEFs also endogenously express MGRN1 ([Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}).

Cumulatively, these results indicate a decrease in MT polymerization when the catalytic activity of MGRN1 is compromised in a cancer-derived cell line as well as primary cells.

MGRN1 does not affect *γ*-tubulin polymerization
------------------------------------------------

Immunocytochemistry of HeLa cells for the endogenous levels of *γ*-tubulin and MGRN1 on mitotic cells showed that although *γ*-tubulin was present only on the spindle poles, MGRN1 decorates the entire spindle apparatus ([Figure 6a](#fig6){ref-type="fig"}). We next checked whether *γ*-tubulin was affected by MGRN1 depletion ([Figures 6b and c](#fig6){ref-type="fig"}). The expression of *γ*-tubulin, its intensity and spread at the poles remain independent of the presence of functional MGRN1, implying that in our system the formation and orientation of spindle poles represent two discrete events.

Furthermore, to check the status of endogenous *γ*-tubulin polymerization, HeLa cells expressing MGRN1, MGRN1ΔR, C316DMGRN1 or depleted for the MGRN1 expression were lysed, separated into S and P fractions and biochemically analyzed ([Figures 6d--g](#fig6){ref-type="fig"}). Again, we could not detect any significant difference in the S/P ratios between the various experimental (with inactive MGRN1) and control samples.

These results again imply that MGRN1 dysfunction does not affect *γ*-tubulin polymerization, its localization or distribution and hence, in turn, does not compromise spindle pole formation while still severely altering the pole orientation.

MGRN1 affects *α*-tubulin polymerization by its polyubiquitination
------------------------------------------------------------------

Tsg101 (tumor suppressor gene 101), a key component of the ESCRT-I (*e*ndosomal *s*orting *c*omplex *r*equired for *t*ransport-I), is the only known physiological substrate that is monoubiquitinated by MGRN1 at multiple sites.^[@bib30]^ Like other ubiquitin E3 ligases, MGRN1 is capable of generating a polyubiquitin ladder and also its autoubiquitination in the presence of a functional RING domain.^[@bib23]^ We therefore tested whether *in vivo α*-tubulin was ubiquitinated by MGRN1. Lysates derived from HeLa cells co-transfected with either MGRN1 or MGRN1ΔR and separated into S and P fractions were immunoprecipitated with *α*-tubulin antibody (Ab) and immunoblotted for endogenous ubiquitin ([Figure 7b](#fig7){ref-type="fig"}). Detection of stronger signal in the P fractions indicates the prevalence of ubiquitinated species in them and also strengthens the argument for the involvement of this modification in the polymerization of *α*-tubulin. Detectable level of ubiquitinated *α*-tubulin is less in the P fraction of MGRN1ΔR as compared with MGRN1.

We next asked whether this was a mono- or polyubiquitination event. To address this, various hemagglutinin (HA)-tagged constructs of different ubiquitin species -- wild-type ubiquitin (Ub), K0, K6, K11, K29, K48 or K63 (ubiquitin mutants with arginine substitutions at all lysine residues except the ones indicated) -- were used ([Figure 7a](#fig7){ref-type="fig"}).^[@bib31],\ [@bib32],\ [@bib33]^

Lysates derived from HeLa cells co-transfected with either MGRN1 or MGRN1ΔR along with the various ubiquitin constructs ([Figure 7c](#fig7){ref-type="fig"}) showed that *α*-tubulin underwent polyubiquitination in the presence of MGRN1 and Ub (lane 1, as evidenced by the detection of a polyubiquitin ladder); however, this was abrogated in the presence of MGRN1ΔR and Ub (lane 2), implying that the inhibition of the MGRN1 catalytic activity affects *α*-tubulin ubiquitination. As MGRN1 is known to multi-monoubiquitinate Tsg101,^[@bib30]^ it was obvious to check the effect of K0 in a similar assay. However, unlike with Ub, we could not detect any multi-monoubiquitination in the presence of MGRN1 and K0 (lane 3) even on a darker exposure. Multi-monoubiquitination was, however, clearly evident in lane 4, having MGRN1ΔR and K0; this could probably mean than in the absence of a catalytically active MGRN1, there was enforced multi-monoubiquitination. Curiously though, lanes 2 and 3 did have a single band (\*) corresponding to a monoubiquitinated *α*-tubulin species ([Figure 7c](#fig7){ref-type="fig"}); a similar band was also evident when analyzed for endogenous ubiquitin ([Figure 7b](#fig7){ref-type="fig"}). These observations led us to believe that monoubiquitination of *α*-tubulin occurred even in the absence of catalytic activity of MGRN1 (as in lanes 2 and 4), with enforced multi-monoubiquitination in the presence of MGRN1ΔR and K0 (lane 4). Results similar to that obtained with Ub and MGRN1/MGRN1ΔR were observed when instead of Ub, its mutant K6 was used (lanes 5 and 6). These data suggest that although MGRN1 promotes polyubiquitination, it also does not encourage multi-monoubiquitination of *α*-tubulin.

No discernible change was detected in the ubiquitination pattern of *β*- and *γ*-tubulins in the presence of the different HA--Ub constructs coexpressed with MGRN1 or MGRN1ΔR ([Figures 7d and e](#fig7){ref-type="fig"}).

The polyubiquitination of *α*-tubulin in the presence of MGRN1, however, does not regulate its protein turnover. This was evident because of two reasons. First, K48-mediated polyubiquitination of *α*-tubulin occurred irrespective of the expression of MGRN1 or MGRN1ΔR. ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}). Similar argument also negates the role of K11, K29 and K63 ubiquitin residues in the polyubiquitin chain extensions ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}). Second, treatment with the proteasomal inhibitor, MG132, similarly affects the S/P ratio of lysates from cells overexpressing MGRN1, MGRN1ΔR or C316DMGRN1 ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}), again stating that MGRN1 does not modulate *α*-tubulin protein levels.

Furthermore, to establish the role of MGRN1-mediated *α*-tubulin ubiquitination in endogenous MT polymerization, at 24 h after transfection, the cell lysates separated into cytosolic (soluble (S)) and insoluble (pellet (P)) fractions were biochemically analyzed to detect any change in *α*-tubulin polymerization among cells expressing Ub, K0 or K6 along with MGRN1 or MGRN1ΔR ([Figures 8a and c](#fig8){ref-type="fig"}). Our results showed that although the S/P ratio is ∼1 in the presence of Ub/K6 and MGRN1, this ratio is \>1.5 in cells expressing K0 and/or MGRN1ΔR ([Figures 8b and d](#fig8){ref-type="fig"}).

However, similar changes in the ubiquitination and polymerization pattern of *β*- and *γ*-tubulins in the presence of the different HA-Ub constructs coexpressed with MGRN1 or MGRN1ΔR could not be detected ([Figures 8e--h](#fig8){ref-type="fig"}).

These results so far taken together hint towards a unique mode of ubiquitin-mediated post-translational modification of *α*-tubulin, where two ubiquitin E3 ligases act. An unknown ligase monoubiquitinates *α*-tubulin and this happens even in the presence of MGRN1ΔR. Either following this or independently, MGRN1 polyubiquitinates *α*-tubulin via noncanonical K6 linkages as a post-translational modification to ensure proper polymerization but not for its degradation. In the absence of a catalytically active MGRN1, multi-monoubiquitination occurs that, however, is insufficient for complete *α*-tubulin polymerization.

Such multiple E3 ligases working together and modifying a protein has been observed previously in case of some of the most important cell cycle regulators that in turn need to be under very tight regulation. The most studied protein to fall in this class is the tumor suppressor p53 (protein 53), known to be ubiquitylated by at least 11 different E3 ligases.^[@bib34]^ Even though these E3 ligases have other targets, they all contribute individually in regulating p53 levels, which is vital for proper cell cycle progression.

Polyubiquitination of *α*-tubulin affects spindle pole orientation
------------------------------------------------------------------

To assess the physiological consequence of MGRN1-mediated polyubiquitination of *α*-tubulin, tilt in spindle poles was used as a read-out. HeLa cells were transfected with Ub or K0 along with MGRN1 or MGRN1ΔR, and the mitotic cells scored for the tilt in the axis of cell division. The spindle angle for cells expressing MGRN1 and Ub was ≤10° for ∼90% of cells (23 out of 27 cells; [Figures 8i and j](#fig8){ref-type="fig"}). However, a tilt of \>10° was observed in ≥55% of cells expressing MGRN1 and K0 or MGRN1ΔR and Ub, and \>10° tilt was observed in 60% of cells expressing MGRN1ΔR along with K0. Thus, just skewing the ubiquitination balance from polyubiquitinated *α*-tubulin to a more predominantly monoubiquitinated species was sufficient to cause spindle misorientation. Results similar to those with MGRN1 and Ub were also seen in the presence of MGRN1 and K6, where ∼70% of transfected cells (21 out of 30 cells) showed angle of tilt ≤10°, whereas ∼67% of cells (20 out of 30 cells) expressing K6 and MGRN1ΔR had \>10° angle of tilt ([Figures 8i and j](#fig8){ref-type="fig"}). Polyubiquitination of *α*-tubulin by catalytically active MGRN1 was a crucial governing factor in the proper orientation of spindle poles.

Discussion
==========

This study elucidates a novel interaction between the cytoskeletal protein *α*-tubulin and MGRN1, whose absence leads to spongiform neurodegeneration or causes significant developmental defects during embryogenesis. The present study for the first time highlights how loss of the ubiquitin E3 ligase activity of MGRN1 affects spindle orientation. In cultured cell systems, MGRN1 physically associated with *α*-tubulin, with an increased preference for polymerized MTs. In cell lines and primary cells, functional inactivation of MGRN1 affected *α*-tubulin polymerization. This also simultaneously coincided with an increase in the angle of tilt in the axis of cell division, resulting in spindle misorientation. The effect of MGRN1 on spindle poles was specific for *α*-tubulin as depletion of this protein did not affect either the expression pattern or polymerization status of *β*- and *γ*-tubulins. Evidence for the importance of the E3 ligase activity of MGRN1 further came from the results that *α*-tubulin polyubiquitination was achieved only in the presence of MGRN1 and Ub and not when MGRN1ΔR and/or K0 were expressed, suggesting that although MGRN1 promotes polyubiquitination, it also does not encourage multi-monoubiquitination of *α*-tubulin. Monoubiquitination of *α*-tubulin by an unknown E3 ligase and MGRN1-mediated polyubiquitination (utilizing the noncanonical K6 linkages) were most likely unrelated, independent events. However, modification of *α*-tubulin by MGRN1 was crucial for proper spindle orientation. Accordingly, catalytic inactivation of MGRN1 and consequential monoubiquitination of *α*-tubulin resulted in misoriented mitotic spindle apparatus. We therefore conclude that ubiquitin-mediated post-translational modification of *α*-tubulin that eventually affects its polymerization occurs via multiple E3 ligases, with MGRN1 being one of them ([Figure 9](#fig9){ref-type="fig"}).

Vertebrates in general exhibit external bilateral symmetry; however, most internal organs such as the heart, lungs and kidney display asymmetry in structure and/or unilateral positioning with respect to the LR axis; interestingly, defects in laterality affects more than 1 in 8000 live births.^[@bib35]^ Various models predict that the LR axis depends on either the presence of cilia-driven extracellular fluid flow^[@bib36],\ [@bib37]^ or recruit 'ciliary\' proteins, such as left--right dynein.^[@bib38],\ [@bib39]^ as factors governing this asymmetry. However, a very recent report has shown in the plant model system (*Arabidopsis thaliana*) that mutations in *α*-tubulin and in a *γ*-tubulin-associated protein (Tubgcp2) play an important role in the symmetry properties of the plant\'s axial organs.^[@bib40],\ [@bib41]^ Similar mutations in vertebrate (*Xenopus laevis*), nematode (*Caenorhabditis elegans*) and mammalian cells affect the generation of LR asymmetry in a cilia-independent manner.^[@bib42]^ Furthermore, expressions of mutant tubulins alter laterality by affecting proper localization of laterality related cargo molecules across the LR axis.^[@bib42]^ This raised the possibility that alterations in *α*-tubulin might as well have a drastic effect on the LR axis of symmetry.

A later study has further shown that mutations in *β*-tubulin disrupt spindle orientation while affecting MT dynamics,^[@bib43]^ thus again emphasizing the importance of tubulins and their polymerization status in spindle orientation. However, this does not rule out the possibility that because of mutations, the association between the MT and the motor proteins may be compromised.

Although the association of tubulins with the motor proteins and hence their role cannot be undermined, the nature of the tubulin subunits themselves are also equally important for MT polymerization, stability and dynamics. Evidences already exist in varied experimental systems where changes in tubulins alter their polymerization status and MT stability, in turn playing a significant role in spindle orientation at the cellular level and the LR axis of symmetry at the organismal level. Hence, we hypothesize that instead of mutations in tubulin, a post-translational modification that would affect its polymerization status as is affected by the E3 ligase, MGRN1, would similarly alter *α*-tubulin monomers and affect *α*-tubulin functions at the cellular as well as the organismal levels.

When studying tubulin polymerization, MT stability and spindle orientation, the emphasis has been on various post-translational modifications other than ubiquitination -- the roles of PARKIN and BRCA1 as ubiquitin E3 ligases of *α*-/*β*- and *γ*-tubulins, respectively, have become evident only recently.^[@bib9],\ [@bib11],\ [@bib12],\ [@bib13]^ It was, hence, plausible to speculate that several other E3 ligases might exist as tubulins are one of the fundamental proteins whose functions regulate a plethora of cellular activities and in turn would require stringent regulation by multiple modifiers. This would be similar to some of the most important cell cycle regulators (like p53, core histone proteins and Rev-erb*α*) that are under very tight regulation by employing multiple E3 ligases.^[@bib34],\ [@bib44],\ [@bib45]^

Although the ubiquitin molecule contains seven lysine residues in positions 6, 11, 27, 29, 33, 48 and 63, the most studied have been homogenous polyubiquitin linkages involving residues 48 and 63.^[@bib46],\ [@bib47]^ The involvement of the other lysine residues in regulating different cellular functions is progressively becoming evident^[@bib45]^ -- K6 polyubiquitin chains being lesser known. The K6 chains have been observed in E3-independent reactions catalyzed by radiation gene 6 (Rad6), the yeast ortholog of UbcH2 (ubiquitin conjugating enzyme 2 (human)).^[@bib48]^ More recently, evidences suggest that autoubiquitination of BRCA1 *in vivo* is mediated by K6 or K29 residues.^[@bib32],\ [@bib49]^ Our present study identifying the polyubiquitination of *α*-tubulin by MGRN1 preferentially utilizing K6, an unconventional site for ubiquitin polymerization, was unexpected. Although our results indicated that MGRN1-mediated *α*-tubulin ubiquitination did not involve K11, K29, K48 or K63 residues, it does not rule out the possibility of utilizing other lysine (K27, K33) residues or by linear chain extension.

Further insight into the mechanism of determination of the LR axis may come from a better understanding of MGRN1 function. Our results could place MGRN1 in the ubiquitous and essential pathway of ubiquitin-dependent post-translational modification of an indispensable cytoskeleton protein. However, its role in the modulation of MT would presumably be nonessential or functionally redundant, despite its rather widespread expression. Such functional redundancy would be essential for the regulation of a fundamental protein such as *α*-tubulin, the disruption of which would affect not only cell division but also intracellular trafficking, cellular motility and morphology.

The study that identified the role of MGRN1 in embryonic patterning LR axis showed similar presence of *Nodal* expression among various MGRN1 mutant embryos.^[@bib28]^ However, the Nodal-responsive genes (*Lefty1*, *Lefty2* and *Paired-like homeodomain transcription factor2*) showed aberration in their expression patterns in the same samples, thus uncoupling the expression of *Nodal* from its responsive genes in the presence of MGRN1 mutants. In plants, tubulin mutations (*spiral1*, *spiral2* and *spiral3*) produce right-handed helical growth; *Lefty1* and *Lefty2* mutants can act as suppressors of *spiral1*.^[@bib40],\ [@bib41]^ However, in *Xenopus*, *α*-tubulin mutations affecting the LR axis also alter *Nodal* expression pattern,^[@bib42]^ hence elucidating that there is a close cross-talk and interplay between tubulins, *Nodal* and nodal-responsive genes; this need not follow a completely linear pathway.

The actual pathway by which MGRN1 alters nodal-responsive genes or helps orient the LR axis is yet under speculation; however, it would be prudent to extrapolate that MGRN1 through its post-translational modification of tubulin might alter the nodal-responsive genes, without affecting *Nodal*.

Finally, our study linking MGRN1 to the MT network via post-translational modification of *α*-tubulin utilizing a more noncanonical K6 polyubiquitin linkage may highlight a key event in the LR patterning during early development in systems where stability of *α*-tubulin subunits supersedes the association between the MT and the motor proteins during such developmental events.

Materials and Methods
=====================

Constructs and antibodies
-------------------------

MGRN1, MGRN1ΔR, MGRN1ΔN and MGRN1ΔC constructs have been described before.^[@bib22]^ The C316DMGRN1 and C299EMGRN1 constructs were generated by standard site-directed mutagenesis techniques. HA-tagged wild-type Ub was a gift of Rafael Mattera (Bethesda, MD, USA); K0, K48 and K63 ubiquitin mutants were gifts of Kah-Leong Lim (Singapore); HA-tagged K6, K11 and K29 ubiquitin mutants were gifts of Tomohiko Ohta (Kawasaki, Japan). Antibodies were from the following sources: *α*-tubulin (Santa Cruz Biotechnology, Dallas, TX, USA), *β*-tubulin (Abcam, Cambridge, UK), *γ*-tubulin (Sigma-Aldrich, St. Louis, MO, USA), dynein (Santa Cruz Biotechnology) and ubiquitin (Sigma-Aldrich). The MGRN1, GFP, RFP and HA antibodies were gifts of Ramanujan S Hegde (Cambridge, UK).

Cell culture, synchronization and immunocytochemistry
-----------------------------------------------------

Cell lines used for the experiment were HeLa (human cervical cancer cell line), HEK 293T (human embryonic kidney cell line), MEF (mouse embryonic fibroblast cells), immortal melanocytes (control melan-a6 or *Mgrn1-*null mutations, melan md1-nc).^[@bib27]^ Culture of HeLa, transient transfections, preparation of stable cell lines, immunofluorescent staining and fluorescence microscopy of fixed cells was as before.^[@bib22],\ [@bib50]^ Briefly, cells were grown in 10% fetal bovine serum (FBS; Gibco, Grand Island, NY, USA)/Dulbecco\'s modified Eagle\'s medium (DMEM; Himedia, Mumbai, India) media at 37°C and 5% CO~2~. At ∼90% confluency, cells were transfected with DNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) as per the manufacturer\'s instructions. At ∼24 h after transfection, cells were lysed using suitable lysis buffer. Immortal melanocytes were grown in 10% fetal calf serum (FCS; Gibco)/RPMI-1640 (Gibco)/200 nM 12-*O*-tetradecanoylphorbol 13-acetate (TPA; Sigma-Aldrich) media at 37°C and 10% CO~2~, as per the guidelines of the Wellcome Trust Functional Genomics Cell Bank. HEK293T (gift of Subrata Banerjee, Kolkata, India) and MEF ((CF-1 strain) gift of Mitradas M Panicker, Bengaluru, India) cells were also grown under standard cell culture conditions. Immortal melanocytes (gift of Ramanujan S Hegde) were obtained from the Wellcome Trust Functional Genomics Cell Bank.

All tissue culture plasticware and Lab-Tek 8-well chambered slides used for microscopy were from Nunc, Rosklide, Denmark, and bottom coverglass dishes used for microscopy were from SPL Lifesciences, Gyeonggi-do, Korea. For synchronization of HeLa cells, thymidine-- synchronization method was followed. Briefly, cells were subjected to 5 mM thymidine (Sigma-Aldrich) treatment for 16--18 h followed by a release of 8 h. This was followed by a Noc (Sigma-Aldrich) block at 100 ng/ml for 16 h. The cells, now blocked at Gap2--mitosis (G2-M), were then allowed to enter mitosis for 60 min and then fixed (as in case of immunocytochemistry) or lysed (for biochemical studies).

Immunohistochemistry was done with minor modifications of earlier methods.^[@bib22],\ [@bib50]^ For immunocytochemistry, cells were fixed with either 10% formaldehyde or methanol as per the requirement of the Ab. Cells were permeabilized using 10%FBS/phosphate buffer saline (PBS)/0.1% saponin (Sigma-Aldrich) for 60 min, followed by overnight staining in primary Ab at 4°C and 60 min of incubation in secondary Ab at room temperature. The samples were then imaged using confocal microscope.

Western blotting and immunoprecipitation
----------------------------------------

The protocol for western blotting was as before.^[@bib22]^ Briefly, 10 or 12% tris-tricine gels were run as per the molecular weight being probed and then the proteins were transferred by wet electrophoretic transfer method for 55 min at 100 V. For immunoprecipitation, the protocol was as described previously^[@bib30]^ with antibodies as indicated in the figures. Briefly, at 24 h after transfection, cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Triton-X, 1% IGEPAL, 1 mM PMSF, protease inhibitor (Sigma-Aldrich)) and then immunoprecipitated using the standard protocol.

Separation of tubulin into polymerized and unpolymerized fractions
------------------------------------------------------------------

Whole-cell lysates were taken from 92 mm culture dishes with 1 ml of lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) at 4°C for 20 min. Soluble and insoluble fractions of cell lysates were separated by ultracentrifugation at 75 000 r.p.m. for 1 h (rotor TLA 120.1, Beckman Coulter, CA, USA). A portion of the lysate (1/15th of the total) was saved before centrifugation. The soluble fraction (S) and insoluble fraction (P) were collected, and pellet was resuspended in Laemelli buffer (1/3 volume of initial lysis buffer used). Equal volumes of supernatant and pellet fractions were then loaded for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed with analysis by western blotting.

FACS analysis
-------------

Cell cycle analysis was done on cells synchronized as before and labeled with 0.01 mM propidium iodide (Thermo Scientific) at 37°C for 20 min. Analysis was done on BD FACS Calibur flow cytometer (Becton Dickinson, San Jose, CA, USA).

Co-sedimentation assay
----------------------

This was performed as described previously^[@bib28]^ with minor modifications. Briefly, cells synchronized and enriched in mitotis were lysed at 4°C in 100 mM 1,4-piperazinediethanesulfonic acid (PIPES), at pH 6.8, 1 mM MgCl~2~, 2 mM ethylene glycol tetra acetic acid (EGTA) and 1% Triton X-100, and spun at 13 000 × *g* for 30 min. To the supernatant thus obtained, purified tubulin (Cytoskeleton, Denver, CO, USA; 4 *μ*g), dithiothreitol (1 mM), guanosine-5′-triphosphate (GTP; 1 mM) and taxol (Sigma-Aldrich) (10 *μ*M) were added to cleared lysates, and incubated for 1 h at 37°C. Nocodazole (100 *μ*M) was added as a negative control. Lysates were layered over a 20% sucrose cushion in the above buffer and spun at 48 000 r.p.m. for 1 h at room temperature (rotor TLA 120.1, Beckman Coulter). Microtubule pellets were collected after removing lysate and cushion, bound proteins were separated by SDS-PAGE and analyzed by western blotting.

Microtubule regrowth assay
--------------------------

At 20 h after transfection, microtubules were depolymerized in 10--20 *μ*M nocodazole in culture medium for 1 h at 37°C. Cells were then washed and incubated in culture medium without nocodazole at 37°C to allow regrowth. Cells were fixed at different time intervals in 10% formalin and processed for immunofluorescence microscopy to examine microtubule regrowth (*α*-tubulin) from spindle poles in metaphase cells and the microtubule meshwork in interphase cells. To study the same in MEFs, the procedure was as described by Godin *et al.*^[@bib7]^ Briefly, microtubules were depolymerized by treating cells with 5 mM nocodazole for 1 h at 37°C and 30 min on ice. After treatment, cells were washed twice with CO~2~ equilibrated medium. Microtubules were allowed to regrow for different times (10 and 15 min). This was followed by fixing and permebealization of cells as described above.

*In vivo* ubiquitination assay
------------------------------

*In vivo* ubiquitination assays were performed as described previously.^[@bib30]^ Briefly, lysates of HeLa cells expressing the indicated GFP-tagged MGRN1, wild-type HA-tagged wild-type Ub or HA-tagged ubiquitin mutants (Ub-K0, Ub-K6, Ub-K11, Ub-K29, Ub-K48 and Ub-K63) were immunoprecipitated with various indicated anti-tubulin antibodies. Ubiquitinated tubulin was detected by immunoblotting with anti-HA antibodies. For analysis of ubiquitination of fractionationed samples, equal volumes of S and P (resuspended in same as initial volume of lysis buffer) were immunoprecipitated with *α*-tubulin Ab and immunoblotted with ubiquitin Ab.

Knockdowns with siRNA
---------------------

ON-TARGETplus SMARTpool siRNAs against MGRN1 and GFP (catalog L-022620-00-0005 and D-001300-01-20; Thermo Scientific Dharmacon Products, Lafayette, CO, USA) were transfected using Lipofectamine 2000 following the manufacturer\'s instructions. Cells to be imaged were divided into two parts, trypsinized and replated -- one set fixed 48 h after siRNA treatment, permeabilized and stained for immunocytochemistry, whereas another set lysed to check for knockdown efficiency biochemically.

Fluorescence microscopy and imaging
-----------------------------------

Fluorescence microscopy was performed utilizing LSM510-Meta and LSM710/ConfoCor 3 microscopy systems (Zeiss, Jena, Germany) equipped with an Ar-ion laser (for GFP excitation or Alexa-Flour 488 with the 488 nm line), a helium--neon (He-Ne) laser (for RFP, Alexa-Fluor 546 and 594 excitation with the 543 line) and a He-Ne laser (for Alexa-Fluor 633 with the 633 line). For all imaging, 63 × 1.4 numerical aperture (NA) oil immersion objective was used. For quantitative analyses and comparisons between multiple samples, images were collected using identical excitation and detection settings. The detector gain settings were chosen to allow imaging of the desired cells within the linear range of the photomultiplier tube without saturating pixels, unless otherwise specified.

Image analyses and calculation of spindle tilt
----------------------------------------------

ImageJ (NIH, Bethesda, MD, USA) was used for all the image analyses reported in the text. For calculation of tilt in cells, *z*-stack images were taken with a *z*-spacing of 0.5--1.0 *μ*m and normalized as required. The distance between the poles was estimated by using ImageJ and then the spindle tilt was calculated as described by Delaval *et al.*^[@bib28]^ The intensity or spread (i.e., area) was calculated using ImageJ. For analysis of long aster MTs, the length of aster rays was measured and the ratio of the length of aster ray to the cell diameter was determined. The central value of the ratio for control cells of 0.15 was taken as a cutoff mark. The number of cells with aster length to cell diameter ratio of \>0.15 was calculated and plotted.
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![Mahogunin interacts with *α*-tubulin. (**a**) Unsynchronized HeLa cells immunostained for endogenous MGRN1 show distinct nuclear exclusion during interphase but decorate the mitotic spindles in dividing cells. (**b**) Synchronized population of HeLa cells, enriched for mitotic cells, were lysed and immunoprecipitated with anti-MGRN1 antibody. Western blots analysis of this with anti-*α*-tubulin antibody shows co-immunoprecipitation of *α*-tubulin with MGRN1. ◂ Marks *α*-tubulin; ← marks MGRN1; Ab, antibody; \* Indicates nonspecific band; and ^\#^ indicates immunoglobulin G (IgG) heavy chain. (**c**) Synchronized HeLa cells were lysed and immunoprecipitated with anti-*α*-tubulin antibody. Immunoblotting with anti-MGRN1 antibody shows co-immunoprecipitation between the two proteins. ^\#\#^ Indicates IgG light chain. (**d**) HeLa cells transiently transfected with the indicated GFP-tagged MGRN1 constructs were synchronized, lysed and immunoprecipitated with anti-GFP antibody. Western blots analysis of this with anti-*α*-tubulin antibody shows co-immunoprecipitation of *α*-tubulin with MGRN1, MGRN1ΔR and MGRN1ΔN but not MGRN1ΔC (top panel). Control blot immunoprecipitated with anti-GFP antibody to show expression of different MGRN1 constructs (bottom panel). (**e**) Synchronized population of HeLa cells immunostained for MGRN1 and *α*-tubulin show colocalization between the two proteins on the mitotic apparatus. The channels for acquiring the images are indicated. Two representative cells (i) and (ii) are shown. (**f**) Colocalization between MGRN1 and *α*-tubulin is detected in mitotic HEK-293T cells. The channels for acquiring the images are indicated. Three representative cells (i), (ii) and (iii) are shown. (**g**) Asynchronous a-6 and md1-nc melanocyte cells were lysed and immunoprecipitated with anti-MGRN1 antibody. Western blots analysis of this with anti-*α*-tubulin antibody shows co-immunoprecipitation of *α*-tubulin with MGRN1 in case of melan a-6 but in the melan md1-nc cells. It should be noted that as IgG heavy chain also migrates at ∼55 KDa, a band (of lower intensity) is detected even in melan md1-nc cells. ◂ Marks MGRN1.(**h**) Asynchronous a-6 and md1-nc melanocyte cells were lysed and immunoprecipitated with anti-*α*-tubulin antibody. Immunoblotting with anti-MGRN1 antibody shows co-immunoprecipitation between the two proteins in case of control melanocyte cell line (melan a-6) only but not in MGRN1-null cell line (melan md1-nc)](cddis20141f1){#fig1}

![Functional depletion of MGRN1 results in tilt in the axis of cell division. (**a**) HeLa cells transiently transfected with the indicated constructs were synchronized and immunostained for *α*-tubulin. Mitotic cells positive for GFP expression were imaged by taking *z*-sections. The images are representative mid-sections (of the *z*-stacks) from at least 30 cells for each of the constructs. A larger proportion of cells expressing catalytically inactive MGRN1 have angle of tilt ≥10° as compared with the control. The lookup table (LUT) images are represented to efficiently locate the spindle poles. (**b**) Histogram plotting the distribution and average of the angles of tilt for cells transfected with cytosolic GFP (control), MGRN1ΔR-GFP or C316DMGRN1-GFP. Over 30 cells analyzed as in (**a**) are represented for each of the constructs. Graph shows results from three independent experiments. \*\**P*≤0.001, using Student\'s *t*-test. Error bars, S.E.M. (**c**) HeLa cells treated with MGRN1 siRNAs or irrelevant siRNAs (GFP siRNAs) were imaged and analyzed as in (**a**). Note that MGRN1 knockdown closely phenocopies MGRN1ΔR expression in affecting the orientation of the axis of cell division. The immunoblot and graph shows a knockdown efficiency of ∼75%. LUT images are represented to efficiently locate the spindle poles. (**d**) Histogram plotting the distribution and average of the angles of tilt for cells treated with MGRN1 siRNAs or irrelevant siRNAs (GFP siRNAs). Over 40 cells analyzed as in (**c**) are represented for each of the siRNA treatments. Graph shows results from three independent experiments. \*\**P*≤0.001, using Student\'s *t*-test. Error bars, S.E.M. (**e**) HeLa cells either untransfected (control) or transiently transfected with the indicated constructs were synchronized and immunostained for α-tubulin. Mitotic cells positive for GFP expression were imaged by taking *z*-sections. The images are representative *z*-projections of at least 30 cells for each of the constructs. The images were acquired with high detector gains and saturating pixels to enable efficient visualization of the thin aster rays and the limiting boundary of the cells. Note shortening of aster rays in MGRN1ΔR-GFP in comparison with either MGRN1-GFP or control cells. The cells analyzed were from the same experiments as in (**a**). LUT images are represented to efficiently locate the spindle poles and thin aster rays. (**f**) Histogram plotting the percentage of cells with long asters (ratio of the aster length to the cell diameter \>0.15) upon expression of the constructs as indicated on the X axis. Over 30 cells were analyzed for this. Graph shows results from three independent experiments. (**g**) HeLa cells treated with MGRN1 siRNAs or irrelevant siRNAs (GFP siRNAs) were imaged and analyzed as in (**f**). The images were acquired with high detector gains and saturating pixels to enable efficient visualization of the thin aster rays and the limiting boundary of the cells. Note that MGRN1 knockdown closely phenocopies MGRN1ΔR expression in length of the aster rays. The cells analyzed were from the same experiments as in (**c**). LUT images are represented to efficiently locate the spindle poles and thin aster rays. (**h**) Histogram similar to (**f**) was plotted to check the effect of MGRN1 knockdown on aster length. Note a marked decrease in aster length in the absence of MGRN1. Approximately 30 cells were analyzed. Graph shows results from three independent experiments](cddis20141f2){#fig2}

![Interaction of MGRN1 with *α*-tubulin is independent of motor protein dynein. (**a**) HeLa cells treated with MGRN1 siRNAs or irrelevant siRNAs (GFP siRNAs) were co-immunostained for dynein intermediate chain (dynein) and MGRN1; mitotic cells were imaged. Note reduced intensity of detectable dynein with MGRN1 knockdown when compared with the control cells. Both the cell populations were imaged with identical microscope settings. The channels for acquiring the images are indicated. (**b**) Histogram plotting the average intensity of dynein on the spindles (in arbitrary units) in cells imaged in (**a**). Note a significant decrease in spindle dynein intensity with MGRN1 siRNA treatment; \*\**P*≤0.01, using Student\'s *t*-test. Error bars, S.E.M. Graph shows results from three independent experiments. (**c**) Same samples as in (**a**) were analyzed and plotted for the average spread of dynein staining at the mitotic apparatus. This difference in the spread between the cells was not significant (*P*≥0.1) using Student\'s *t*-test. Error bars, S.E.M. Graph shows results from three independent experiments. (**d**) HeLa cells transiently transfected with the indicated constructs were treated with nocodazole and allowed to recover for various time points (30, 60 and 90 min). The cells were immunostained for *α*-tubulin. Note an increase in ectopic poles with the functional depletion of MGRN1. The channel for acquiring the images is indicated. (**e**) Cells imaged in (**d**) were analyzed for the total number of ectopic poles. The ratio of the average number of ectopic poles between MGRN1ΔR/C316DMGRN1 and MGRN1 was plotted for each of the time points. Note that this ratio remains similar over time. Graph shows results from three independent experiments](cddis20141f3){#fig3}

![MGRN1 affects polymerization of *α*-tubulin. (**a**) Microtubule pulldown assay shows that MGRN1 co-pelleted with taxol-stabilized microtubules in mitotic HeLa cell lysates, indicated by (▸). Nocodazole (Noc) inhibition of microtubule polymerization was used as negative control. The blot is a representative of at least three experiments. (**b**) Hela cells lysates, transiently expressing the indicated constructs, were fractionated to separate polymerized and unpolymerized fractions by high-speed ultracentrifugation; the fractionated samples along with total lysates were immunoblotted for *α*-tubulin. The levels of *α*-tubulin in the total lysates serve as loading control; the expression of the various constructs was biochemically analyzed with anti-GFP antibody. The blots are representative of at least five experiments. (**c**) The immunoblots generated in (**b**) were analyzed for the ratio of unpolymerized to polymerized *α*-tubulin. Note an increase in this ratio upon functional depletion of MGRN1, an indication of a compromise in tubulin polymerization. \**P*\<0.05, \*\**P*\<0.01, using Student\'s *t*-test. Error bars, S.E.M. (**d**) HeLa cells treated with MGRN1 or GFP siRNAs were fractionated and immunoblotted as in (**b**). The blots are representative of at least three experiments. The inset immunoblot shows a efficient knockdown of MGRN1. (**e**) The immunoblots generated in (**d**) were analyzed for the ratio of unpolymerized to polymerized *α*-tubulin. Note that MGRN1 siRNA treatment phenocopies expression of catalytically inactive MGRN1 expression. Error bars, S.E.M. (**f**) MEF cell lysates, transiently expressing the indicated constructs, were fractionated and immunoblotted as in (**b**). Note that faint (F) and dark (D) exposures of the blot show negligible amounts of detectable *α*-tubulin in the pellet fraction with MGRN1ΔR. (**g**) The immunoblot generated in (**f**) was analyzed for the ratio of unpolymerized to polymerized *α*-tubulin. Note that the functional depletion of MGRN1 has very similar effects on primary and HeLa cells. (**h**) Lysates from melanocytes, melan a-6 and md1-nc were fractionated into polymerized and unpolymerized fractions; these samples along with the total cell lysates were immunoblotted for *α*-tubulin. The blot shown is representative from three experiments. (**i**) The immunoblots generated in (**h**) were analyzed for the ratio of unpolymerized to polymerized *α*-tubulin. Note that this ratio in melan md1-nc (MGRN1 null cells) is very similar to that of MGRN1 knockdown in HeLa cells as shown in (**d**) and (**e**). Error bars, S.E.M. (**j**) The same samples analyzed in (**b**) were immunoblotted for *β*-tubulin. The levels of *β*-tubulin in the total lysates serve as loading control. The blots are representative of at least three experiments. (**k**) The immunoblots generated in (**j**) were analyzed for the ratio of unpolymerized to polymerized *β*-tubulin. Note no change in this ratio across samples. (**l**) The same samples analyzed in (**d**) were immunoblotted for *β*-tubulin. The levels of *β*-tubulin in the total lysates serve as loading control. The blots are representative of at least three experiments. (**m**) The immunoblots generated in (**l**) were analyzed for the ratio of unpolymerized to polymerized *β*-tubulin. Note no change in this ratio across samples](cddis20141f4){#fig4}

![MGRN1 affects microtubule regrowth. (**a**) HeLa cells transiently transfected with the indicated constructs were treated with nocodazole, allowed to recover for 30 and 60 min and microtubule regrowth was monitored by immunostaining with *α*-tubulin antibody. Insets of higher magnification show punctate *α*-tubulin staining in the presence of MGRN1ΔR contrary to a well-formed MT network in MGRN1-expressing cells. (**b**) HeLa cells treated with MGRN1 or GFP siRNAs were subjected to similar treatments as in (**a**), with recovery times of 30 and 60 min. Insets of higher magnification show punctate *α*-tubulin staining in the presence of MGRN1 siRNA, similar to MGRN1ΔR](cddis20141f5){#fig5}

![MGRN1 does not affect the spindle poles. (**a**) Asynchronous HeLa cells were co-immunostained for MGRN1 and *γ*-tubulin; mitotic cells were imaged. *γ*-Tubulin is detected at the spindle poles, whereas MGRN1 is seen to decorate the entire mitotic apparatus. (**b**) HeLa cells treated with MGRN1 or GFP siRNAs were co-immunostained for MGRN1 and *γ*-tubulin; mitotic cells were imaged. Similar *γ*-tubulin staining is detected at the spindle poles, irrespective of the treatments. (**c**) Cells imaged in (**b**) were analyzed for the spread of *γ*-tubulin staining at the spindle poles. Histogram plotting the percentage of cells at different of areas of spread as indicated on the X axis. Over 80 cells from 4 independent experiments were analyzed as represented for each of the siRNA treatments. (**d**) The same samples analyzed in [Figure 4b](#fig4){ref-type="fig"} were immunoblotted for *γ*-tubulin. The levels of γ-tubulin in the total lysates serve as loading control. The blots are representative of at least three experiments. (**e**) The immunoblots generated in (**d**) were analyzed for the ratio of unpolymerized to polymerized γ-tubulin. Note no change in this ratio across samples. (**f**) The same samples analyzed in [Figure 4d](#fig4){ref-type="fig"} were immunoblotted for *γ*-tubulin. The levels of *γ*-tubulin in the total lysates serve as loading control. The blots are representative of at least three experiments. (**g**) The immunoblots generated in (**f**) were analyzed for the ratio of unpolymerized to polymerized *β*-tubulin. Note no change in this ratio across samples](cddis20141f6){#fig6}

![MGRN1 mediates *α*-tubulin polyubiquitination. (**a**) A cartoon representation of the sequence of ubiquitin, the lysine residues involved in ubiquitination and their putative role in the cell. (**b**) HeLa cells transiently transfected with MGRN1-GFP or MGRN1ΔR-GFP were fractionated to separate polymerized and unpolymerized fractions by high-speed ultracentrifugation, and the fractionated samples were immunoprecipitated with anti-*α*-tubulin antibody. Enhanced *in vivo* ubiquitination was detected in pellet fractions compared with the supernatants by immunoblotting with anti-ubiquitin antibody. Faint and dark exposures of the anti-ubiquitin blot are shown. Expression of MGRN1ΔR compromises the polyubiquitination in the pellet fraction. Expressions of *α*-tubulin in the various fractions and total lysates along with that of MGRN1 in the total lysates serve as loading control. \* Indicates monoubiquitinated *α*-tubulin; ^\#^ indicates immunoglobulin G IgG heavy chain; ^\#\#^ indicates IgG light chain. (**c**) HeLa cells transiently co-transfected with HA-Ub, HA-K0 or HA-K6 constructs along with MGRN1-GFP or MGRN1ΔR-GFP were lysed and immunoprecipitated with anti *α*-tubulin antibody. *In vivo* ubiquitination was detected by immunoblotting with anti-HA antibody. Faint and dark exposures of the anti-HA blot are shown. Polyubiquitination is detected in the presence of MGRN1 along with either Ub or K6. The input levels of *α*-tubulin in the total lysates serve as loading control. (**d**) HeLa cells transiently co-transfected with HA-Ub, HA-K0 or HA-K6 constructs along with MGRN1-GFP or MGRN1ΔR-GFP were lysed, immunoprecipitated with anti *β*-tubulin antibody and immunoblotted with anti-HA antibody. The input levels of *β*-tubulin in the total lysates serve as loading control. (**e**) HeLa cells transiently co-transfected with HA-Ub, HA-K0 or HA-K6 constructs along with MGRN1-GFP or MGRN1ΔR-GFP were lysed, immunoprecipitated with anti *γ*-tubulin antibody and immunoblotted with anti-HA antibody. The input levels of *γ*-tubulin in the total lysates serve as loading control](cddis20141f7){#fig7}

![MGRN1 promotes *α*-tubulin polymerization by polyubiquitination. (**a**) HeLa cells transfected with MGRN1-GFP or MGRN1ΔR-GFP along with HA--Ub or HA--K0 were fractionated and immunoblotted with *α*-tubulin to check for the status of *α*-tubulin polymerization. The levels of *α*-tubulin in the total lysates serve as loading control. The blot is representative of at least three experiments. (**b**) The immunoblots from (**a**) were quantitated and analyzed for the ratio of unpolymerized to polymerized tubulin. Note that the functional MGRN1 and Ub are required for efficient *α*-tubulin polymerization. Error bars, S.E.M. (**c**) HeLa cells transfected with MGRN1-GFP or MGRN1ΔR-GFP along with HA-K6 were similarly treated as in (**a**). The levels of *α*-tubulin in the total lysates serve as loading control.The blot is representative of at least three experiments. (**d**) Quantitation and analyses of immunoblots from (**c**) show that significantly more *α*-tubulin exists in the polymerized state in the presence of MGRN1 and K6. Error bars, S.E.M. (**e**) The same samples generated in (**a**) and (**c**) were immunoblotted with *β*-tubulin. The levels of *β*-tubulin in the total lysates serve as loading control. The blot is representative of at least three experiments. (**f**) Quantitation and analyses of immunoblots from (**e**) show similar pattern of *β*-tubulin polymerization across samples. Error bars, S.E.M. (**g**) The same samples generated in (**a**) and (**c**) were immunoblotted with *γ*-tubulin. The levels of *γ*-tubulin in the total lysates serve as loading control. The blot is representative of at least three experiments. (**h**) Quantitation and analyses of immunoblots from (**g**) show similar pattern of *γ*-tubulin polymerization across different trasfections. Error bars, S.E.M. (**i**) HeLa cells transfected with MGRN1-GFP or MGRN1ΔR-GFP along with HA--Ub, HA--K0 or HA--K6 were imaged and mitotic cells analyzed for the tilt in axis of division as in [Figure 2](#fig2){ref-type="fig"}. Note that conditions that support polyubiquitination (as in the presence of MGRN1 along with Ub or K6) only result in normal axis of cell division (with spindle tilt ≤10°). (**j**) The cells imaged in (**i**) were analyzed the amount of tilt in the axis of cell division was calculated similar to [Figure 2](#fig2){ref-type="fig"}. The graph shows the percentage of cells with abnormal tilt (\>10°, in dark gray) and those with normal axis of division (tilt ≤10°, in light gray). Similar effect on the spindle angles was observed in the Ub and K6](cddis20141f8){#fig8}

![Schematic diagram summarizing the results. Tb denotes *α*-tubulin. Although MGRN1-mediated polyubiquitination of *α*-tubulin is crucial for its polymerization and proper orientation of the axis of cell division, its monoubiquitination by an unknown E3 ligase may be an independent event. Monoubiquitination of *α*-tubulin preceeding MGRN1-mediated polyubiquitination also remains a possibility](cddis20141f9){#fig9}
